Skip to content
Search

Latest Stories

Ceuta Group appoints P&G’s Michael Yates as chief operating officer

Ceuta Group has appointed Michael Yates as chief operating officer (COO).

In his new role, he will focus on the exploration of future acquisitions to support the Group’s growth plans and ensure it continues to provide innovative services and unlock new opportunities for its clients.


Prior to joining Ceuta Group, Yates was associated with Procter & Gamble (P&G) for more than 25 years. His career started in the UK and progressed through senior commercial and managing director roles across Europe, Africa and Asia.

During his time at P&G, Yates gained insight and experience in building brands in the UK and globally. He has broad category experience across food & drink as well as health, wellness and personal care, having worked with brands such as Pringles, Sunny Delight, Oral B, Vicks, Head & Shoulders and Pantene.

With extensive international experience, Michael brings client-side knowledge and insight of successfully expanding brands and adapting business models for markets across the globe. His appointment bolsters Ceuta Group’s leadership structure and will support the Group’s growth plans and delivery of superior client service.

Commenting on his appointment, Yates said, “Having known and respected Ceuta Group for many years for its strong culture and unique business model, I am excited to be joining Ceuta Group as COO. I’m looking forward to meeting both longstanding and new clients to hear how we can support them in their growth ambitions both in the UK and internationally.”

Yates’s immediate focus will be to meet with and hear from clients, colleagues and partners to help inform the Group’s future thinking and strategic choices.

Yates added, “It’s a challenging time for brands and businesses, and so effective collaboration between the Group and our clients has never been more important. Now is not the time for brands to stand still, business models need to be constructively disrupted to ensure they are responsive to changing consumer needs and continue to deliver value. I look forward to working with our clients across the health and personal care industry and building their brands across multiple channels and markets.”

Edwin Bessant, Ceuta Group CEO, said, “We’re delighted to welcome Michael to Ceuta Group. His international experience and focus on collaboration will be an asset for the Group and our clients.

“The introduction of the COO role to our leadership team comes at a pivotal time and will support the Group’s plans for growth. This evolution will also allow us to align even closer to our clients to help them successfully adapt and navigate today’s changing environment.”

More For You

GP surgery upgrades for annual appointments

The surgeries will have additional space to “see more patients, boost productivity and improve patient care”

Pic credit: iStock

GP surgery upgrades to create 8.3 million more annual appointments

Over 1,000 GP surgeries will have their premises modernised to meet the needs of a further 8.3 million appointments each year, the government has announced.

Backed by a cash injection of over £102 million, the surgeries will have additional space to “see more patients, boost productivity and improve patient care”.

Keep ReadingShow less
Wales boosts funding for pharmacy-led UTI and sore throat test services

The sore throat test (STTT) and treat service will be widely available

Pic credit: istock

Welsh pharmacies receive funding boost for clinical services

Two key clinical services will be available in 99 per cent of community pharmacies across Wales after a boost in funding.

The sore throat test (STTT) and treat service and the urinary tract infection (UTI) service have both benefitted from contractual negotiations between the Welsh Government and Community Pharmacy Wales (CPW).

Keep ReadingShow less
Paul Bennett
Paul Bennett, CEO, Royal Pharmaceutical Society
Paul Bennett, CEO, Royal Pharmaceutical Society

Pharmacists need to take advantage of independent prescribing pathways, says Bennett

Independent prescribing will be a “significant point” in the history of community pharmacy, according to Royal Pharmaceutical Society chief executive Paul Bennett.

Last month, the RPS announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

Keep ReadingShow less
Community Pharmacy Scotland secures £10m reimbursement uplift amid ongoing negotiations

Negotiations continue on the Global Sum element of remuneration.

Getty Images

Community Pharmacy Scotland secures £120m reimbursement deal for 2025/26

Community Pharmacy Scotland (CPS) has accepted the Scottish government’s initial financial offer for the 2025/26 fiscal year, securing a guaranteed minimum reimbursement of £120 million for community pharmacies — up from £110 million from 2024/25.

The agreement marks the first phase of ongoing negotiations surrounding community pharmacy funding for the upcoming financial year.

Keep ReadingShow less